SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-009108
Filing Date
2010-01-21
Accepted
2010-01-20 21:58:34
Documents
5
Period of Report
2010-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 25237
2 CERTIFICATE OF AMENDMENT dex35.htm EX-3.5 9469
3 OPINION OF COOLEY GODWARD KRONISH LLP dex51.htm EX-5.1 7011
4 THIRD AGREEMENT REGARDING PRIVATE PLACEMENT OF SECURITIES dex1067.htm EX-10.67 35055
5 SALES AGREEMENT dex1068.htm EX-10.68 164167
  Complete submission text file 0001193125-10-009108.txt   242717
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 10537539
SIC: 2834 Pharmaceutical Preparations